Clinical Trial Update: Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy [Phase 4]

View source ↗

Summary

This update describes a Phase 4 clinical trial focused on developing technology to validate surrogate prognostic markers in patients with diabetic nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Snippet

Sponsor: Seoul National University Hospital | Conditions: Diabetic Nephropathy | Phase 4 | Status: UNKNOWN